1. A Randomized, Single‐dose, Phase I Clinical Comparison of a Trastuzumab Biosimilar With a Reference Trastuzumab Formulation in Healthy Chinese Male Volunteers. Issue 2 (1st November 2022) Authors: Pu, Huahua; Jia, Jingying; Zhao, Chunyang; Hou, Sheng; Guo, Huaizu; Li, Jing; Qian, Weizhu; Wang, Hao; Sun, Chan; Zou, Yang Journal: Clinical pharmacology in drug development Issue: Volume 12:Issue 2(2023) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bioequivalence and Safety of Levetiracetam Granules and Oral Solution: A Randomized, Single‐Dose, 2‐Period Crossover Study in Healthy Chinese Volunteers Under a Fasting Condition. Issue 3 (14th February 2022) Authors: Liu, Yun; Zou, Yang; Wang, Yijun; Jiang, Fan; Xu, Wenjing; Liu, Shuyun; Jia, Jingying; Yu, Chen; Fang, Liming; Hu, Liwei; Zhang, Kanyin E.; Long, Jingwen; Pu, Huahua Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 3(2022) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗